The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy

Slides:

Advertisements

Similar presentations

Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis Kristian Reich, MD, PhD, Julia Deinzer,

Advertisements

Can an airway challenge test predict respiratory diseases

The effects of the spleen tyrosine kinase inhibitor fostamatinib on ambulatory blood pressure in patients with active rheumatoid arthritis: results of.

Sangshin Park, DVM, MPH, PhD, Eun-Hee Lee, PhD, Younglim Kho, PhD

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications Judie A. Howrylak, MD, Anne L.

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study Anna.

Relevance of specific IgE antibody titer to the prevalence, severity, and persistence of asthma among 19-year-olds in northern Sweden Matthew S. Perzanowski,

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma Ronaldo P. Panganiban, BS, Yanli Wang, BS, Judie Howrylak, MD, PhD,

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Kyoung-Bok Min, MD, PhD, Jin-Young Min, PhD

Regulatory T cells as a biomarker for response to adalimumab in rheumatoid arthritis Dao X. Nguyen, BSc, Alice Cotton, RN, BSc, Laura Attipoe, MBBS, Coziana.

Ann-Marie M. Schoos, MD, PhD, Jacob D

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications Judie A. Howrylak, MD, Anne L.

Relevance of specific IgE antibody titer to the prevalence, severity, and persistence of asthma among 19-year-olds in northern Sweden Matthew S. Perzanowski,

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

The Editors' Choice Journal of Allergy and Clinical Immunology

Mechanistic correlates of clinical responses to omalizumab in the setting of oral immunotherapy for milk allergy Pamela A. Frischmeyer-Guerrerio, MD,

Katherine J. Baines, PhD, BBiomedSci (Hons), Jodie L

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study Anna.

Prenatal adverse life events increase the risk for atopic diseases in children, which is enhanced in the absence of a maternal atopic predisposition

Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease Chihiro Mitsui, MD, Keiichi Kajiwara, BSc, Emiko Ono, MD, PhD,

A history of pollen mapping and surveillance: The relations between natural history and clinical allergy Gregg Mitman, PhD Journal of Allergy and Clinical.

Basophils, high-affinity IgE receptors, and CCL2 in human anaphylaxis

Blood DNA methylation biomarkers predict clinical reactivity in food-sensitized infants David Martino, PhD, Thanh Dang, PhD, Alexandra Sexton-Oates, BSc,

Adnan Custovic, MD, PhD, Hans-Joachim Sonntag, MRes, Iain E

Role of p63/p73 in epithelial remodeling and their response to steroid treatment in nasal polyposis Chun Wei Li, PhD, Li Shi, MD, Ke Ke Zhang, MD, Tian.

Serum from Asian patients with atopic dermatitis is characterized by TH2/TH22 activation, which is highly correlated with nonlesional skin measures Huei-Chi.

Comparative transcriptomic analyses of atopic dermatitis and psoriasis reveal shared neutrophilic inflammation David F. Choy, BS, Daniel K. Hsu, PhD,

An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation Teresa Song, BS, Ana B. Pavel, PhD, Huei-Chi Wen, MD, PhD,

Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point Emma C.Y. Hilton, PhD, Paul G.

A randomized multicenter study evaluating Xolair persistence of response after long- term therapy Dennis Ledford, MD, William Busse, MD, Benjamin Trzaskoma,

Asthma Exacerbations and Triggers in Children in TENOR: Impact on Quality of Life Bradley E. Chipps, MD, Tmirah Haselkorn, PhD, Karin Rosén, MD, PhD,

T-cell receptor diversity is selectively skewed in T-cell populations of patients with Wiskott-Aldrich syndrome Junfeng Wu, MD, Dawei Liu, MS, Wenwei.

Physical exercise modulates the homeostasis of human regulatory T cells Max Weinhold, MA, Alexander Shimabukuro-Vornhagen, MD, Axel Franke, MD, Sebastian.

Can an airway challenge test predict respiratory diseases

Omalizumab Effectiveness by Biomarker Status in Patients with Asthma: Evidence From PROSPERO, A Prospective Real-World Study Thomas B. Casale, MD, Allan.

Example choice set: DAS28, 28 joint disease activity score; EUR, Euro; QALY, quality-adjusted life year. * In the choice sets, changes of the individual.

Asthma symptom re-emergence after omalizumab withdrawal correlates well with increasing IgE and decreasing pharmacokinetic concentrations Raymond G.

Panimmunoglobulin and IgE-selective extracorporeal immunoadsorption in patients with severe atopic dermatitis Kristian Reich, MD, PhD, Julia Deinzer,

Association of disease parameters at the time of methotrexate reinitiation during the OLE based on propensity score matching. Association of disease parameters.

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Classification of childhood asthma phenotypes and long-term clinical responses to inhaled anti-inflammatory medications Judie A. Howrylak, MD, Anne L.

Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy Annebeth E. Flinterman, MD, Edward F. Knol,

Alvin W. L. Schadenberg, MD, Theo van den Broek, MD, Marten A

A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy Satya D. Narisety,

IL-5 T-cell responses to house dust mite are associated with the development of allergen-specific IgE responses and asthma in the first 5 years of life

Jon Genuneit, MD, MSc Journal of Allergy and Clinical Immunology

Development and Validation of Personalized Prediction to Estimate Future Risk of Severe Exacerbations and Uncontrolled Asthma in Patients with Asthma,

Patterns and predictors of atopic dermatitis disease control past childhood: An observational cohort study Katrina Abuabara, MD, MA, Ole Hoffstad, MS,

Is eczema really on the increase worldwide?

Peanut oral immunotherapy modifies IgE and IgG4 responses to major peanut allergens Brian P. Vickery, MD, Jing Lin, PhD, Michael Kulis, PhD, Zhiyan Fu,

Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study George Du Toit, MBBCh, FRCPCH, Graham.

Polyunsaturated fatty acids in plasma at 8 years and subsequent allergic disease Jessica Magnusson, PhD, Sandra Ekström, MSc, Inger Kull, PhD, Niclas.

Serum autoreactivity predicts time to response to omalizumab therapy in chronic spontaneous urticaria Janine Gericke, PhD, Martin Metz, MD, Tatevik Ohanyan,

Suzanne Havstad, MA, Ganesa Wegienka, PhD, Edward M

Syk expression and IgE-mediated histamine release in basophils as biomarkers for predicting the clinical efficacy of omalizumab Donald W. MacGlashan,

Effect of aging on sputum inflammation and asthma control

Michael B. Fessler, MD, Mark W

Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine–associated anaphylaxis Mizuho Nagao, MD, PhD, Takao.

Cox proportional-hazards model of time to first RA flare after treatment withdrawal for patients who entered the re-treatment period (n=146). Cox proportional-hazards.

Reply Journal of Allergy and Clinical Immunology

Interrupting IL-6–receptor signaling improves atopic dermatitis but associates with bacterial superinfection Alexander A. Navarini, MD, PhD, Lars E.

Personal and parental nativity as risk factors for food sensitization

News & Notes Journal of Allergy and Clinical Immunology

Toward improved prediction of risk for atopy and asthma among preschoolers: A prospective cohort study Patrick G. Holt, FAA, Julie Rowe, PhD, Merci Kusel,

Reslizumab in children and adolescents with eosinophilic esophagitis: Results of a double-blind, randomized, placebo-controlled trial Jonathan M. Spergel,

Analysis of basophil activation in patients with aspirin-exacerbated respiratory disease Chihiro Mitsui, MD, Keiichi Kajiwara, BSc, Emiko Ono, MD, PhD,

Presentation transcript:

The interferon gene signature is increased in patients with early treatment-naive rheumatoid arthritis and predicts a poorer response to initial therapy Faye A.H. Cooles, MBChB, PhD, Amy E. Anderson, PhD, Dennis W. Lendrem, PhD, Julie Norris, BSc, Arthur G. Pratt, MBChB, PhD, Catharien M.U. Hilkens, PhD, John D. Isaacs, MBBS, PhD Journal of Allergy and Clinical Immunology Volume 141, Issue 1, Pages 445-448.e4 (January 2018) DOI: 10.1016/j.jaci.2017.08.026 Copyright © 2017 The Authors Terms and Conditions

Fig 1 IGS in patients with early RA: Prevalence and disease activity associations. Patients with early RA (n = 50), established RA (n = 25), and established SLE (n = 23) and healthy control subjects (HC; n = 23) had their whole blood IGS measured. A, Proportion of patients with a positive IGS in patients with early RA (42%), established RA (21%), and SLE (56%). B, IGS expression across different disease cohorts. C, Patients with early RA (n = 11): longitudinal IGS expression at baseline (0 months) and 1, 3, and 6 months after initiation of DMARD therapy. Gray shading depicts median IGS. Box and whisker plots show medians and interquartile ranges. For both Fig 1, B and C, analysis included rank transformation of IGS scores, which were tested for differences between groups after adjustment for age and sex with the Tukey multiple comparison test applied. D and E, Plot depicts age- and sex-matched multiple regression between baseline IGS and baseline DAS28 scores in patients with early (Fig 1, D) and established (Fig 1, E) RA. F, Swollen joint count (SJC; P = .017) and tender joint count (TJC; P = .043) were the key drivers of association between baseline DAS28 scores and baseline IGS. Multiple regression analysis: *P < .05, **P < .01, and ***P < .001. Journal of Allergy and Clinical Immunology 2018 141, 445-448.e4DOI: (10.1016/j.jaci.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Fig 2 IGS in patients with early RA predicts worse disease activity, a poorer response to initial therapy, and increased glucocorticoid requirements. Patients with early RA (n = 32) had baseline IGS calculated and disease activity parameters assessed at 6 months after diagnosis and initiation of treatment. A, Plot depicts age- and sex-corrected multiple regression between baseline IGS and DAS28 scores at 6 months. B, Relationship between the probability of achieving a good EULAR response at 6 months and baseline IGS (nominal logistic regression, age and sex corrected). C, The plot depicts the relationship between the probability of receiving additional glucocorticoids in the first 6 months after diagnosis and baseline IGS. Numbers denote the number of additional glucocorticoid administrations (0-3) in the first 6 months. Baseline IGS significantly predicted additional glucocorticoid requirements (ordinal logistic regression with bootstrap probabilities included, P = .0003). The higher the baseline IGS, the greater the probability that patients fall into the regions indicating 1 or more additional glucocorticoid doses. Journal of Allergy and Clinical Immunology 2018 141, 445-448.e4DOI: (10.1016/j.jaci.2017.08.026) Copyright © 2017 The Authors Terms and Conditions

Fig E1 Additional prediction model figures. Patients with early RA (n = 32) had baseline ESR levels, CRP levels, and DAS28 scores calculated, and disease activity parameters were assessed at 6 months after diagnosis and initiation of treatment. A, Plot depicts age- and sex-corrected multiple regression between baseline ESR levels, CRP levels, and DAS28 scores and DAS28 scores at 6 months. B, Relationship between the probability of achieving a good EULAR response at 6 months and baseline ESR levels, CRP levels, and DAS28 scores (nominal logistic regression age and sex corrected). C, Plot depicts the relationship between the probability of receiving additional glucocorticoids in the first 6 months after diagnosis and baseline ESR levels, CRP levels, and DAS28 scores. Numbers denote numbers of additional glucocorticoid administrations (0-3) in the first 6 months. Baseline ESR levels, CRP levels, and DAS28 scores did not significantly predict additional glucocorticoid requirements (P = .345, P = .615, and P = .699, respectively; ordinal logistic regression with bootstrap probabilities included). Journal of Allergy and Clinical Immunology 2018 141, 445-448.e4DOI: (10.1016/j.jaci.2017.08.026) Copyright © 2017 The Authors Terms and Conditions